
    
      Immunotherapy and irreversible electroporation in the treatment of advanced pancreatic
      adenocarcinoma. This is a Phase II study in which all patients undergoing irreversible
      electroporation of locally advanced pancreatic adenocarcinoma will be treated with nivolumab
      post-operatively.
    
  